ucsf logobch logo

Nicholas Fidelman, MD

Interventional RadiologyDirector, Interventional Oncology, San Francisco
Portrait of Nicholas Fidelman
Portrait of Nicholas Fidelman
ucsf logobch logo

Nicholas Fidelman, MD

Interventional RadiologyDirector, Interventional Oncology, San Francisco

On this page

About me

Dr. Nicholas Fidelman is a radiologist who specializes in caring for patients with liver cancer, metastatic colorectal cancer and neuroendocrine tumors. He has expertise in liver-directed therapy, a treatment that directly targets cancer in the liver. He also is experienced in treating portal hypertension (high blood pressure in the veins connecting the digestive organs to the liver), biliary disorders (which affect the bile ducts and gallbladder), urinary system disorders, and in performing dialysis interventions (minimally invasive procedures to restore blood flow in vessels used for dialysis).

Fidelman's research focuses on clinical trials investigating novel treatments for liver cancer, outcomes of commonly performed procedures in interventional radiology, and on improving the safety and efficacy of image-guided treatments.

Fidelman earned his medical degree from UCSF, where he also completed a residency in radiology and a fellowship in vascular and interventional radiology.

Education & training

Board certification

  • Interventional and Diagnostic Radiology, American Board of Radiology

Fellowship

  • Vascular & Interventional Radiology, UCSF Graduate Medical Education

Residency

  • Diagnostic Radiology, UCSF Graduate Medical Education

Internship

  • Internal Medicine, St. Mary's Medical Center, GME

Degree

  • MD, UCSF School of Medicine

My expertise

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.